$1.85 Billion is the total value of DLD Asset Management, LP's 89 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 77.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MDCO | Sell | MEDICINES COput | $278,255,000 | +67.9% | 3,275,900 | -1.1% | 15.00% | +78.9% |
| Sell | CAESARS ENTMT CORPnote 5.000%10/0 | $79,767,000 | -42.5% | 41,263,230 | -49.2% | 4.30% | -38.7% | |
| Sell | NICE SYS INCnote 1.250% 1/1 | $26,618,000 | -52.7% | 13,909,000 | -55.7% | 1.44% | -49.5% | |
| WBC | Sell | WABCO HLDGS INC | $21,896,000 | -23.4% | 161,597 | -24.4% | 1.18% | -18.3% |
| WCG | Sell | WELLCARE HEALTH PLANS INC | $19,813,000 | -4.4% | 60,000 | -25.0% | 1.07% | +1.8% |
| Sell | ANTHEM INCnote 2.750%10/1 | $14,755,000 | -75.8% | 3,500,000 | -80.8% | 0.80% | -74.2% | |
| ACAD | Sell | ACADIA PHARMACEUTICALS INCcall | $9,309,000 | -1.6% | 217,600 | -17.3% | 0.50% | +4.8% |
| Sell | WRIGHT MED GROUP N Vnote 2.250%11/1 | $3,638,000 | -88.2% | 2,500,000 | -90.5% | 0.20% | -87.4% | |
| PACB | Sell | PACIFIC BIOSCIENCES CALIF IN | $3,084,000 | -40.2% | 600,000 | -40.0% | 0.17% | -36.4% |
| UA | Sell | UNDER ARMOUR INCcl c | $2,294,000 | -29.7% | 119,607 | -33.6% | 0.12% | -24.8% |
| RTRX | Sell | RETROPHIN INCput | $2,006,000 | -68.9% | 141,500 | -74.6% | 0.11% | -67.0% |
| PIRS | Exit | PIERIS PHARMACEUTICALS INC | $0 | – | -25,000 | -100.0% | -0.00% | – |
| AVTR | Exit | AVANTOR INCput | $0 | – | -10,000 | -100.0% | -0.01% | – |
| SPR | Exit | SPIRIT AEROSYSTEMS HLDGS INC | $0 | – | -2,500 | -100.0% | -0.01% | – |
| STI | Exit | SUNTRUST BKS INC | $0 | – | -3,543 | -100.0% | -0.01% | – |
| VSM | Exit | VERSUM MATLS INCput | $0 | – | -7,800 | -100.0% | -0.02% | – |
| AMRN | Exit | AMARIN CORP PLCspons adr new | $0 | – | -50,000 | -100.0% | -0.04% | – |
| ENTX | Exit | ENTERA BIO LTD | $0 | – | -369,000 | -100.0% | -0.05% | – |
| CVRS | Exit | CORINDUS VASCULAR ROBOTICS I | $0 | – | -219,479 | -100.0% | -0.05% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INCput | $0 | – | -38,100 | -100.0% | -0.07% | – |
| HHC | Exit | HOWARD HUGHES CORP | $0 | – | -11,000 | -100.0% | -0.07% | – |
| ITCI | Exit | INTRA CELLULAR THERAPIES INCcall | $0 | – | -202,000 | -100.0% | -0.08% | – |
| AVTRPRA | Exit | AVANTOR INC6.25 pfd cnv sr | $0 | – | -30,000 | -100.0% | -0.08% | – |
| FOMX | Exit | FOAMIX PHARMACEUTICALS LTD | $0 | – | -525,000 | -100.0% | -0.08% | – |
| Exit | TWILIO INCnote 0.250% 6/0 | $0 | – | -1,000,000 | -100.0% | -0.08% | – | |
| GOSS | Exit | GOSSAMER BIO INCcall | $0 | – | -102,000 | -100.0% | -0.09% | – |
| ILMN | Exit | ILLUMINA INC | $0 | – | -7,200 | -100.0% | -0.11% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INCput | $0 | – | -31,500 | -100.0% | -0.12% | – |
| CARA | Exit | CARA THERAPEUTICS INCput | $0 | – | -164,900 | -100.0% | -0.15% | – |
| LTXB | Exit | LEGACY TEX FINL GROUP INC | $0 | – | -69,634 | -100.0% | -0.15% | – |
| PSDO | Exit | PRESIDIO INC | $0 | – | -190,000 | -100.0% | -0.16% | – |
| SYMC | Exit | SYMANTEC CORP | $0 | – | -170,000 | -100.0% | -0.20% | – |
| GOSS | Exit | GOSSAMER BIO INCput | $0 | – | -258,600 | -100.0% | -0.22% | – |
| PVTL | Exit | PIVOTAL SOFTWARE INC | $0 | – | -300,000 | -100.0% | -0.23% | – |
| MCRN | Exit | MILACRON HLDGS CORP | $0 | – | -300,000 | -100.0% | -0.25% | – |
| GHDX | Exit | GENOMIC HEALTH INC | $0 | – | -80,000 | -100.0% | -0.28% | – |
| CBLK | Exit | CARBON BLACK INC | $0 | – | -230,087 | -100.0% | -0.30% | – |
| VIAB | Exit | VIACOM INC NEWcl b | $0 | – | -257,903 | -100.0% | -0.31% | – |
| GWR | Exit | GENESEE & WYO INCcl a | $0 | – | -62,516 | -100.0% | -0.35% | – |
| CBM | Exit | CAMBREX CORP | $0 | – | -120,000 | -100.0% | -0.36% | – |
| GWPH | Exit | GW PHARMACEUTICALS PLCput | $0 | – | -68,000 | -100.0% | -0.40% | – |
| ONCE | Exit | SPARK THERAPEUTICS INC | $0 | – | -142,500 | -100.0% | -0.70% | – |
| Exit | MEDICINES COnote 2.500% 1/1 | $0 | – | -22,000,000 | -100.0% | -1.70% | – | |
| CELG | Exit | CELGENE CORP | $0 | – | -450,000 | -100.0% | -2.26% | – |
| BIIB | Exit | BIOGEN INCcall | $0 | – | -303,400 | -100.0% | -3.58% | – |
| SPY | Exit | SPDR S&P 500 ETF TRcall | $0 | – | -250,000 | -100.0% | -3.75% | – |
| Exit | SAREPTA THERAPEUTICS INCdbcv 1.500%11/1 | $0 | – | -66,000,000 | -100.0% | -4.47% | – | |
| Exit | ADVANCED MICRO DEVICES INCnote 2.125% 9/0 | $0 | – | -78,774,000 | -100.0% | -14.92% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TELEPHONE & DATA SYS INC | 18 | Q2 2023 | 0.5% |
| WORLD WRESTLING ENTMT INC | 17 | Q1 2023 | 6.3% |
| BOOKING HOLDINGS INC | 15 | Q4 2022 | 1.2% |
| LIBERTY MEDIA CORP DELAWARE | 14 | Q4 2022 | 7.5% |
| WAYFAIR INC | 14 | Q3 2023 | 3.2% |
| DISCOVERY INC | 14 | Q2 2021 | 1.9% |
| BOOKING HOLDINGS INC | 14 | Q4 2022 | 0.9% |
| GENWORTH FINL INC | 14 | Q3 2023 | 0.3% |
| GUESS INC | 13 | Q3 2023 | 2.8% |
| LIBERTY GLOBAL PLC | 13 | Q2 2021 | 0.8% |
View DLD Asset Management, LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-12 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR/A | 2022-02-22 |
| 13F-HR | 2022-02-14 |
View DLD Asset Management, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.